The BioMed X Institute
BioMed X inaugurates its new institute in the USA with a research project on complex ex vivo models of tissue inflammation in collaboration with AbbVie.
NEW HAVEN, CT / ACCESSWIRE / October 31, 2023 / BioMed X, an independent biomedical research institute, announces the start of a research project in collaboration with AbbVie to be hosted by the new BioMed X Institute in New Haven, CT, USA. The project aims to generate an organotypic human arterial model with sufficient complexity to recapitulate key characteristics of chronic autoimmune disease onset, progression, and resolution, with the long-term goal of advancing patient treatment.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Dr. Alicia Cutler is the Group Leader of the "Complex Human Ex Vivo Models of Tissue Inflammation" project. Before accepting this position at BioMed X, Alicia was a Research Associate in the Department of Molecular, Cell, and Developmental Biology at the University of Colorado Boulder, USA. "My initial training in biochemistry and stem cell biology positioned me to expand my research interests towards tissue engineering and bioprinting. I am very excited about this opportunity to start a new research group on this topic with the support of BioMed X and AbbVie," explains Alicia.
The new BioMed X Institute is located in New Haven, CT, in the Elm City Bioscience Center, neighboring Yale University, and will be managed by Mark Johnston, an experienced biotech CEO and entrepreneur. "Alicia was the winner of a competitive boot camp we conducted with our partners at AbbVie, following BioMed X's unique crowdsourcing model. I am thrilled she accepted to be our first BioMed X US Group Leader," says Mark Johnston, Chief Executive Officer of BioMed X USA.
This is already the second research collaboration between BioMed X and AbbVie. Dr. Christian Tidona, Founder and Managing Director of the BioMed X Institute, explains: "After 10 years of success stories at our institute in Heidelberg, Germany, we have decided to extend our operations overseas. Our first project with AbbVie in Heidelberg was successfully completed in 2019, focusing on Tau-mediated neurodegeneration in Alzheimer's disease. We are grateful that AbbVie has agreed to partner with us again for our first project on US territory," adds Tidona.
"We are pleased to expand our collaboration with BioMed X to the US and continue the work to enhance our understanding of human disease biology. This is a unique opportunity to create the complex in vitro model systems needed to advance the field of immunology research and beyond," said Dr. Timothy Radstake, Vice President & Global Head, Immunology Discovery Research at AbbVie.
About BioMed X
BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world's brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds - academia and industry - and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.
Contact Information
Flavia-Bianca Cristian
Recruiting & Communications Manager
fbc@bio.mx
+49 6221 426 11 706
Related Images
SOURCE: BioMed X Institute
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/797155/biomed-x-and-abbvie-start-new-research-project-in-the-usa
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
OMP Unveils UnisonIQ: the AI Breakthrough Transforming Supply Chain Decision-Making2.10.2025 17:00:00 CEST | Press release
ANTWERPEN, BE / ACCESS Newswire / October 2, 2025 / OMP, a global leader in supply chain planning solutions, today announced the availability of UnisonIQ, a game-changing AI orchestration framework that transforms supply chain decision-making through human-AI synergy. Embedded within OMP's Unison Planning™ platform, UnisonIQ delivers insightful always-on agents that leverage Unison Companion, a generative AI-based assistant, and market-leading AI engines.UnisonIQ Bridging four decades of supply chain innovation with the agentic age As supply chains face unprecedented complexity and volatility, organizations need more than traditional planning tools - they need intelligent systems that can adapt, learn, and act autonomously. Gartner predicts that by 2030, 50% of cross-functional supply chain management (SCM) solutions will use intelligent agents to autonomously execute decisions in the ecosystem. With UnisonIQ, industry leaders can orchestrate decision-centric planning across their glob
Transoft Solutions Receives AiRAP Accreditation2.10.2025 11:00:00 CEST | Press release
Transoft Solutions Named First North American Company to Become an Accredited AiRAP Data Provider for iRAP Global Road Assessments VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / October 2, 2025 / Transoft Solutions, a global leader in transportation engineering, analysis, and operations software, is now officially an accredited AiRAP data provider, reinforcing its support for the International Road Assessment Programme's (iRAP) vision of a world free of high-risk roads. This achievement enables more efficient iRAP Star Rating assessments performed by road safety professionals and practitioners. iRAP's Star Rating methodology uses a predictive, risk-based approach to assess roads universally by reviewing attributes present along the road corridor. The time-consuming traditional method of conducting an iRAP Star Rating involves accredited coders manually reviewing video footage of road, 100m at a time, and coding more than 50 road attributes. These attributes are then processed through
Saudi Electricity Company Appoints Eng. Khalid Bin Salem AlGhamdi as Chief Executive Officer1.10.2025 21:45:00 CEST | Press release
Saudi Electricity Company Appoints Eng. Khalid Bin Salem AlGhamdi as Chief Executive Officer RIYADH, SA / ACCESS Newswire / October 1, 2025 / The Board of Directors of the Saudi Electricity Company (SEC) has announced the appointment of Eng. Khalid bin Salem AlGhamdi as the company's Chief Executive Officer, effective October 1st 2025 . The decision reflects the Board's confidence in the capabilities of Saudi talent and their vital role in advancing the Kingdom's electricity sector, a key enabler of the country's ongoing economic and social transformation.Eng. Khalid bin Salem AlGhamdi Saudi Electricity Company Appoints Eng. Khalid bin Salem AlGhamdi as Chief Executive Officer Commenting on his appointment, Eng. AlGhamdi expressed his deep pride in this trust, extending his sincere gratitude to the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and to His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister - may God pr
Preservica Launches New AI in Archiving & Digital Preservation Workshop Series1.10.2025 15:00:00 CEST | Press release
OXFORD, UK AND BOSTON, MA / ACCESS Newswire / October 1, 2025 / Preservica, the leader in AI-powered Active Digital Preservation™, is proud to announce the launch of a new AI in Archiving & Digital Preservation - Practitioner Workshop Series. The program is designed to enable archivists, records managers and information professionals to learn, explore and be part of actively shaping the safe and effective use of human-centric AI assistance for archival enrichment, information capture, long-term preservation and enhanced discovery. Led by Preservica's expert Product team and featuring guest speakers from across the industry, the series offers a unique opportunity for participants to: Build practical skills in applying AI with human oversight Collaborate and learn from peers and real-world best practices Experience AI in action and provide feedback on emerging tools Gain control and confidence in how and where AI is applied Over the course of the Series, individual workshops will explore
Innodata to Host Exclusive GenAI Summit in San Francisco October 9, 20251.10.2025 14:30:00 CEST | Press release
Event to be elite gathering of enterprise AI leaders, executives, and innovators charting the path of generative AI NEW YORK, NY / ACCESS Newswire / October 1, 2025 / INNODATA INC. (Nasdaq:INOD), a global data engineering company, today announced it will host the Innodata GenAI Summit on October 9, 2025, at the Contemporary Jewish Museum in San Francisco, California. Designed exclusively for VP+ and C-suite leaders, the summit will bring together executives, AI pioneers, and enterprise innovators to explore how generative AI is transforming industries. The event will feature strategic sessions, executive panels, and curated networking opportunities, with zero vendor pitches and maximum strategic value. "The Innodata GenAI Summit is designed to be a premier executive experience for leaders shaping the future of enterprise AI," said Jack Abuhoff, CEO of Innodata. "We believe the summit will be an environment where decision-makers can share insights, build meaningful connections, and gain
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom